Free Trial

Lifeward (LFWD) Competitors

Lifeward logo
$0.56 -0.01 (-2.45%)
Closing price 04:00 PM Eastern
Extended Trading
$0.56 +0.01 (+0.99%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LFWD vs. NMTC, POCI, TMDIF, VVOS, CLGN, RVP, ICU, NRXS, COCH, and DRIO

Should you be buying Lifeward stock or one of its competitors? The main competitors of Lifeward include NeuroOne Medical Technologies (NMTC), Precision Optics (POCI), Titan Medical (TMDIF), Vivos Therapeutics (VVOS), CollPlant Biotechnologies (CLGN), Retractable Technologies (RVP), SeaStar Medical (ICU), NeurAxis (NRXS), Envoy Medical (COCH), and DarioHealth (DRIO). These companies are all part of the "medical equipment" industry.

Lifeward vs. Its Competitors

NeuroOne Medical Technologies (NASDAQ:NMTC) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 8.9% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 2.7% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

NeuroOne Medical Technologies has a net margin of -55.44% compared to Lifeward's net margin of -121.80%. Lifeward's return on equity of -137.91% beat NeuroOne Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroOne Medical Technologies-55.44% -163.49% -78.67%
Lifeward -121.80%-137.91%-90.28%

NeuroOne Medical Technologies presently has a consensus target price of $1.45, indicating a potential upside of 98.39%. Lifeward has a consensus target price of $9.00, indicating a potential upside of 1,517.25%. Given Lifeward's higher possible upside, analysts clearly believe Lifeward is more favorable than NeuroOne Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroOne Medical Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Lifeward
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

NeuroOne Medical Technologies has higher earnings, but lower revenue than Lifeward. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroOne Medical Technologies$3.45M10.59-$12.32M-$0.15-4.87
Lifeward$25.66M0.34-$28.94M-$3.12-0.18

In the previous week, Lifeward had 2 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 3 mentions for Lifeward and 1 mentions for NeuroOne Medical Technologies. Lifeward's average media sentiment score of 0.50 beat NeuroOne Medical Technologies' score of -1.00 indicating that Lifeward is being referred to more favorably in the news media.

Company Overall Sentiment
NeuroOne Medical Technologies Negative
Lifeward Positive

NeuroOne Medical Technologies has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, Lifeward has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500.

Summary

Lifeward beats NeuroOne Medical Technologies on 8 of the 15 factors compared between the two stocks.

Get Lifeward News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFWD vs. The Competition

MetricLifewardINTERNET SOFTWARE IndustryComputer SectorNASDAQ Exchange
Market Cap$8.96M$19.30B$30.33B$9.85B
Dividend YieldN/A3.44%3.16%4.51%
P/E Ratio-0.1875.95436.8426.42
Price / Sales0.3464.911,618.03119.09
Price / CashN/A84.3936.1158.92
Price / Book0.268.227.006.06
Net Income-$28.94M$355.31M$807.65M$266.28M
7 Day Performance-10.26%-2.30%-1.13%-0.76%
1 Month Performance-20.50%0.20%2.35%3.83%
1 Year Performance-82.33%65.40%24,024.61%24.39%

Lifeward Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFWD
Lifeward
3.1895 of 5 stars
$0.56
-2.5%
$9.00
+1,517.3%
-82.5%$8.96M$25.66M-0.1860Short Interest ↓
NMTC
NeuroOne Medical Technologies
1.7118 of 5 stars
$0.78
-0.5%
$1.45
+86.6%
-6.3%$38.85M$3.45M-5.1820Negative News
Short Interest ↑
POCI
Precision Optics
N/A$4.82
-2.6%
N/A-17.1%$36.97M$19.10M-5.4280Gap Down
TMDIF
Titan Medical
N/A$0.31
-12.9%
N/A+811.4%$35.66M$17.63M-0.2550
VVOS
Vivos Therapeutics
0.3029 of 5 stars
$4.68
+1.1%
$4.82
+2.9%
+73.9%$34.90M$14.39M-2.77160
CLGN
CollPlant Biotechnologies
2.9033 of 5 stars
$2.66
+1.1%
$11.50
+332.3%
-49.4%$33.84M$510K-2.3570Short Interest ↓
RVP
Retractable Technologies
2.9121 of 5 stars
$0.83
-2.1%
N/A-14.7%$24.79M$38.16M-1.53240Positive News
Short Interest ↓
ICU
SeaStar Medical
1.1361 of 5 stars
$0.88
-1.0%
N/A-82.3%$24.60M$140K-0.342Short Interest ↓
NRXS
NeurAxis
3.5157 of 5 stars
$2.49
-2.0%
$7.00
+181.1%
-18.8%$24.55M$3.22M-1.3519Short Interest ↓
COCH
Envoy Medical
2.5286 of 5 stars
$1.13
+0.9%
$9.25
+718.6%
-60.1%$24.15M$220K-0.7834Analyst Revision
High Trading Volume
DRIO
DarioHealth
1.9278 of 5 stars
$0.53
-4.0%
$2.00
+278.8%
-43.3%$23.98M$27.04M-0.80200Stock Split

Related Companies and Tools


This page (NASDAQ:LFWD) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners